Series A - Peptilogics
Investment Firm
Overview
Clinical-stage therapeutics company with a computational deep learning peptide design platform • Design > discovery
Announced Date
Sep 29, 2017
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 Stefan Roever |
Round Details and Background
Peptilogics raised $5500000 on 2017-09-29 in Series A
Clinical-stage therapeutics company with a computational deep learning peptide design platform • Design > discovery
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 15, 2013 |  Convertible Note - Peptilogics | 1 | - | 75.0K |
| Jan 05, 2022 | Grant - Peptilogics | 1 | - | undefined |
| Sep 29, 2017 | Series A - Peptilogics | 3 | - | 5.5M |
| Jan 21, 2016 | Seed Round - Peptilogics | - | 416.8K |
Recent Activity
There is no recent news or activity for this profile.